07:39 AMWatson Pharmaceuticals (WPI): Q3 EPS of $0.66 beats by $0.01. Revenue of $662M (+3.3%) vs. $688M. (PR)
Comment!
Wednesday, July 29, 2009
09:19 AMWatson Pharmaceuticals (WPI): Q2 EPS of $0.61 beats by $0.04. Revenue of $678M (+9%) vs. $664M. Raises guidance for FY '09, sees EPS of $2.50-2.58 vs. $2.45 consensus. Shares -3.3% premarket. (PR)
1 Comment
08:46 AM
Jurors resume deliberations today in a $170M lawsuit against Watson Pharmaceuticals (WPI) by the state of Alabama, after being overheard yelling among themselves and asking whether they could rule against both plaintiff and defendant.
2 Comments
Wednesday, June 17, 2009
08:29 AM
Watson Pharmaceuticals (WPI) to acquire privately-held Arrow Group for $1.75B in cash and stock. Watson describes Arrow as one of the fastest-growing generic pharma firms in the world. At $647M sales in 2008, Arrow's sales have grown a compound 67%/year since 2001. WPI -4.6% premarket.
Comment!
Thursday, April 30, 2009
08:05 AMWatson Pharmaceuticals (WPI): Q1 EPS of $0.58 beats by $0.09. Revenue of $667M (+6.5%) vs. $638M. Shares +6.0% premarket. (PR)
Comment!